Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 267,299 | 274,352 | 336,837 | 307,976 | 310,521 |
| Cost of Goods | 52,518 | 50,715 | 57,014 | 57,651 | 59,020 |
| Gross Profit | 214,781 | 223,637 | 279,823 | 250,325 | 251,501 |
| Operating Expenses | 183,794 | 183,582 | 226,117 | 206,779 | 198,983 |
| Operating Income | 31,505 | 40,770 | 53,720 | 44,197 | 52,538 |
| Interest Expense | 18 | 18 | 16 | 5 | -1,108 |
| Other Income | 159 | -402 | 606 | 144 | 885 |
| Pre-tax Income | 31,646 | 40,350 | 54,310 | 44,336 | 54,531 |
| Income Tax | 11,326 | 13,020 | 16,076 | 13,715 | 14,902 |
| Net Income Continuous | 20,320 | 27,330 | 38,234 | 30,621 | 39,629 |
| Net Income | $20,320 | $27,330 | $38,234 | $30,621 | $39,629 |
| EPS Basic Total Ops | 1.05 | 1.37 | 1.89 | 1.47 | 1.87 |
| EPS Basic Continuous Ops | 1.06 | 1.37 | 1.89 | 1.47 | 1.88 |
| EPS Diluted Total Ops | 1.05 | 1.36 | 1.87 | 1.45 | 1.87 |
| EPS Diluted Continuous Ops | 1.05 | 1.36 | 1.87 | 1.45 | 1.87 |
| EBITDA(a) | $37,166 | $46,254 | $59,278 | $49,687 | $58,055 |